These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 3533316)

  • 21. Prevention of rethrombosis after coronary thrombolysis in a chronic canine model. II. Adjunctive therapy with r-hirudin.
    Rote WE; Mu DX; Bates ER; Nedelman MA; Lucchesi BR
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):203-11. PubMed ID: 7511748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Thrombolytic therapy in acute coronary syndrome--Part I].
    Barbash G
    Harefuah; 1989 Feb; 116(3):152-8. PubMed ID: 2653984
    [No Abstract]   [Full Text] [Related]  

  • 23. [Anticoagulant therapy in acute myocardial infarct. Therapeutic indications based on incomplete experimental data].
    Goldman L
    Recenti Prog Med; 1980 Apr; 68(4):382-93. PubMed ID: 6992245
    [No Abstract]   [Full Text] [Related]  

  • 24. Antithrombotic therapy in coronary artery disease.
    Di Salvo TG; Fuster V
    Curr Opin Lipidol; 1994 Aug; 5(4):290-304. PubMed ID: 7981960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial.
    Sabatine MS; Morrow DA; Montalescot G; Dellborg M; Leiva-Pons JL; Keltai M; Murphy SA; McCabe CH; Gibson CM; Cannon CP; Antman EM; Braunwald E;
    Circulation; 2005 Dec; 112(25):3846-54. PubMed ID: 16291601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Thrombolytic treatment in the acute phase of myocardial infarction. Evaluation in 1986].
    Kher A; Michel PL; Samama M; Acar J
    Ann Med Interne (Paris); 1986; 137(7):584-9. PubMed ID: 3545003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of experimental coronary thrombosis by hirudin.
    Bucha E; Nowak G; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):52-8. PubMed ID: 2459032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of antithrombotic drugs in older people.
    Tufano A; Cerbone AM; Di Minno G
    Minerva Med; 2002 Feb; 93(1):13-26. PubMed ID: 11850611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of rethrombosis after coronary thrombolysis in a chronic canine model. I. Adjunctive therapy with monoclonal antibody 7E3 F(ab')2 fragment.
    Rote WE; Mu DX; Bates ER; Nedelman MA; Lucchesi BR
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):194-202. PubMed ID: 7511747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping out the future in venous thromboembolism and acute coronary syndromes.
    Heit JA
    Semin Thromb Hemost; 2002 Aug; 28 Suppl 3():33-9. PubMed ID: 12232821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabis-induced coronary artery thrombosis and acute anterior myocardial infarction in a young man.
    Tatli E; Yilmaztepe M; Altun G; Altun A
    Int J Cardiol; 2007 Sep; 120(3):420-2. PubMed ID: 17097170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination antithrombotic therapy in acute myocardial infarction.
    Rihn TL; Vanscoy GJ
    Am J Health Syst Pharm; 2002 Oct; 59(19):1882-5. PubMed ID: 12374078
    [No Abstract]   [Full Text] [Related]  

  • 33. What an interventional cardiologist should know about the pharmacological treatment of acute myocardial infarction.
    Verheugt FW
    Semin Interv Cardiol; 1999 Mar; 4(1):17-20. PubMed ID: 10406064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombosis: its role and prevention in cardiovascular events-Part II.
    Harker LA; Thompson AR; Harlan JM
    West J Med; 1981 Apr; 134(4):315-32. PubMed ID: 7018088
    [No Abstract]   [Full Text] [Related]  

  • 35. [New agents and challenges in the antithrombotic management of arterial diseases].
    Udvardy M; Rák K
    Orv Hetil; 1997 Jan; 138(2):59-65. PubMed ID: 9064617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel synthetic inhibitor of factor Xa decreases early reocclusion and improves 24-h patency after coronary fibrinolysis in dogs.
    Abendschein DR; Baum PK; Verhallen P; Eisenberg PR; Sullivan ME; Light DR
    J Pharmacol Exp Ther; 2001 Feb; 296(2):567-72. PubMed ID: 11160645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update in cardiology.
    Sanz J; Fuster V
    Ann Intern Med; 2010 Jun; 152(12):786-91. PubMed ID: 20410449
    [No Abstract]   [Full Text] [Related]  

  • 38. [Secondary prevention after acute myocardial infarction: aspirin, warfarin or both?].
    Reikvam A; Madsen S; Landmark K
    Tidsskr Nor Laegeforen; 2003 Jun; 123(13-14):1838-40. PubMed ID: 12830258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of cardiovascular events after acute coronary syndrome.
    Wallentin L
    Semin Vasc Med; 2005 Aug; 5(3):293-300. PubMed ID: 16123917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Thrombolytic agents].
    Lablanche JM
    Rev Prat; 1989 Feb; 39(3):259-62. PubMed ID: 2922567
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.